ArticleScience translational medicine2018

Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.

Lei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.